Conjugated Linoleic Acid

Monographie
319produits
single · Oral

Noms acceptés (anglais)

3
CLA(common)Conjugated linoleic acid(common)Conjugated linoleic acid(proper)

Noms acceptés (français)

3
CLA(common)Conjugated linoleic acid(common)Conjugated linoleic acid(proper)

Allégations santé approuvées

6
  • May help to support a modest improvement to body composition when used with a program of reduced intake of dietary calories and increased physical activity
  • May help to support a modest reduction in fat mass when used with a program of reduced intake of dietary calories and increased physical activity
  • If a body composition/reduction of fat mass claim is made:
  • Improvement of body composition/reduction of fat mass is a long-term process and must therefore be associated with a long-term intervention
  • Medicinal ingredient with diuretic properties may be included in products associated with weight management, however no diuretic claim can be applied as it is associated with a short-term duration of use (occasional use only)
  • Stimulant laxatives cannot be present at therapeutic dose in products associated with weight management as their short term duration of use is not compatible with the duration of use for weight management

Allégations santé approuvées (Français)

6
  • May help to support a modest improvement to body composition when used with a program of reduced intake of dietary calories and increased physical activity
  • May help to support a modest reduction in fat mass when used with a program of reduced intake of dietary calories and increased physical activity
  • If a body composition/reduction of fat mass claim is made:
  • Improvement of body composition/reduction of fat mass is a long-term process and must therefore be associated with a long-term intervention
  • Medicinal ingredient with diuretic properties may be included in products associated with weight management, however no diuretic claim can be applied as it is associated with a short-term duration of use (occasional use only)
  • Stimulant laxatives cannot be present at therapeutic dose in products associated with weight management as their short term duration of use is not compatible with the duration of use for weight management

Plages de doses approuvées

3
PopulationPlage de dosesFréquence
Adults 18 years and older3–5 gramsper day
Adults 18 years and older4–6.5 g—
Adults 18 years and older3–5 g—

Mises en garde et contre-indications

6
cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if you are obese or have cardiovascular disease (CVD) risk factors (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Basu et al. 2000a,b).
cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if your goal is to achieve weight loss.
contraindicationDo not use if you are pregnant (HC 2010).
contraindicationDo not use if you have cardiovascular disease (CVD), diabetes, metabolic syndrome or insulin resistance (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Moloney et al. 2004; Basu et al. 2000a,b).
adverse_reactionWhen using this product you may experience gastrointestinal discomfort/disturbances (Gaullier et al. 2007; Pinkoski et al. 2006; Berven et al. 2000; Blankson et al. 2000).

Ingrédients couverts

2
CLAConjugated linoleic acid

Validez contre la monographie Conjugated Linoleic Acid

Vérifiez si votre produit respecte toutes les exigences de la monographie Conjugated Linoleic Acid — doses, allégations, mises en garde et étiquettes bilingues.

Analyser gratuitement